LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Zimmer Biomet Holdings Inc

Gesloten

SectorGezondheidszorg

94.04 0.74

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

90.62

Max

94.1

Belangrijke statistieken

By Trading Economics

Inkomsten

-92M

139M

Verkoop

242M

2.2B

K/W

Sectorgemiddelde

28.025

66.845

EPS

2.42

Dividendrendement

0.98

Winstmarge

6.213

Werknemers

17,000

EBITDA

-184M

454M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+8.14% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.98%

2.25%

Volgende Winsten

4 mei 2026

Volgende dividenddatum

30 apr 2026

Volgende Ex Dividend datum

31 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.9B

20B

Vorige openingsprijs

93.3

Vorige sluitingsprijs

94.04

Nieuwssentiment

By Acuity

11%

89%

14 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Zimmer Biomet Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 nov 2025, 19:38 UTC

Winsten

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Winsten

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Peer Vergelijking

Prijswijziging

Zimmer Biomet Holdings Inc Prognose

Koersdoel

By TipRanks

8.14% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 101.06 USD  8.14%

Hoogste 120 USD

Laagste 88 USD

Gebaseerd op 20 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zimmer Biomet Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

20 ratings

5

Buy

12

Hold

3

Sell

Technische score

By Trading Central

92.27 / 100.88Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Strong Bearish Evidence

Sentiment

By Acuity

14 / 351 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat